Q32 Bio Inc Analysis
| Analyst Ratings |
|
Average Target Price
|
77.80
|
|
Average Rating
|
4.83
|
|
# Strong Buys
|
5
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
-1.40
|
-1.46
|
-0.06
|
-4.07%
|
|
2024-06-30
|
-1.04
|
-1.42
|
-0.38
|
-36.54%
|
|
2024-03-31
|
-2.32
|
-14.95
|
-12.63
|
-544.40%
|
|
2023-12-31
|
-0.30
|
-0.28
|
0.02
|
6.67%
|
|
2023-09-30
|
-7.56
|
-10.26
|
-2.70
|
-35.71%
|
|
2023-06-30
|
0.00
|
-10.91
|
0.00
|
0.00%
|
|
2023-03-31
|
0.00
|
-9.00
|
0.00
|
0.00%
|
|
2022-12-31
|
0.00
|
-10.74
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-17.83
|
|
2023-12-31
|
-30.45
|
|
2022-12-31
|
-1.78
|
|
2021-12-31
|
-30.33
|
|
2020-12-31
|
-50.54
|
|
2019-12-31
|
-44.48
|
|
2018-12-31
|
-27.66
|